RELX PLC (AMS:REN)
Netherlands
· Delayed Price · Currency is EUR 47.50
-0.08 (-0.17%)
May 8, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Risk | 3.25B |
Log In |
Log In |
Log In |
Log In |
| Risk Growth | 18.48% |
Log In |
Log In |
Log In |
Log In |
| Scientific, Technical & Medical | 3.05B |
Log In |
Log In |
Log In |
Log In |
| Scientific, Technical & Medical Growth | 9.99% |
Log In |
Log In |
Log In |
Log In |
| Legal | 1.90B |
Log In |
Log In |
Log In |
Log In |
| Legal Growth | 11.31% |
Log In |
Log In |
Log In |
Log In |
| Exhibitions | 1.24B |
Log In |
Log In |
Log In |
Log In |
| Exhibitions Growth | 58.31% |
Log In |
Log In |
Log In |
Log In |
| Subscriptions | 5.03B |
Log In |
Log In |
Log In |
Log In |
| Subscriptions Growth | - |
Log In |
Log In |
Log In |
Log In |
| Transactional | 4.41B |
Log In |
Log In |
Log In |
Log In |
| Transactional Growth | - |
Log In |
Log In |
Log In |
Log In |
| Electronic | 7.82B |
Log In |
Log In |
Log In |
Log In |
| Electronic Growth | - |
Log In |
Log In |
Log In |
Log In |
| Face-to-Face | 1.19B |
Log In |
Log In |
Log In |
Log In |
| Face-to-Face Growth | - |
Log In |
Log In |
Log In |
Log In |
| Print | 421.00M |
Log In |
Log In |
Log In |
Log In |
| Print Growth | - |
Log In |
Log In |
Log In |
Log In |
| North America | 5.50B |
Log In |
Log In |
Log In |
Log In |
| North America Growth | - |
Log In |
Log In |
Log In |
Log In |
| Europe | 2.03B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In |
| Rest of World | 1.91B |
Log In |
Log In |
Log In |
Log In |
| Rest of World Growth | - |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Risk Adjusted Operating Profit | 1.23B |
Log In |
Log In |
Log In |
Log In |
| Risk Adjusted Operating Profit Growth | 9.14% |
Log In |
Log In |
Log In |
Log In |
| Scientific, Technical & Medical Adjusted Operating Profit | 1.17B |
Log In |
Log In |
Log In |
Log In |
| Scientific, Technical & Medical Adjusted Operating Profit Growth | 2.83% |
Log In |
Log In |
Log In |
Log In |
| Legal Adjusted Operating Profit | 412.00M |
Log In |
Log In |
Log In |
Log In |
| Legal Adjusted Operating Profit Growth | 6.76% |
Log In |
Log In |
Log In |
Log In |
| Exhibitions Adjusted Operating Profit | 398.00M |
Log In |
Log In |
Log In |
Log In |
| Exhibitions Adjusted Operating Profit Growth | 69.90% |
Log In |
Log In |
Log In |
Log In |